Article
Mutations of BRAF and KRAS2 in the development of Barrett's adenocarcinoma.
Oncogene - 15 Jan 2004
Sommerer Florian, Vieth Michael, Markwarth Annett, Röhrich Knut, Vomschloss Susanne, May Andrea, Ell Christian, Stolte Manfred, Hengge Ulrich R, Wittekind Christian, Tannapfel Andrea
Abstract excerpt
Activation of the Raf/MEK/ERK (MAPK) signal transduction cascade by RAS mutations has been found in a variety of human cancers. Mutations of BRAF provide an alternative route for activation of this signalling pathway. To determine the role of mutations in BRAF and KRAS2 in the neoplastic progress...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
